Assetmark Inc. Has $62.89 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Assetmark Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 107,557 shares of the healthcare conglomerate’s stock after purchasing an additional 8,314 shares during the period. Assetmark Inc.’s holdings in UnitedHealth Group were worth $62,886,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC increased its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group during the third quarter valued at $32,000. Finally, Delos Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Robert W. Baird increased their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

UNH opened at $616.33 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $619.80. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The stock’s 50 day simple moving average is $581.93 and its 200-day simple moving average is $545.03. The stock has a market cap of $567.20 billion, a PE ratio of 40.15, a P/E/G ratio of 1.75 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.56 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.